Anthraquinone

Anthraquinone

SCHEMBL1087010

Cl.N#N.O=C1c2ccccc2C(=O)c2ccccc21

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Anthraquinone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA known ✓ P21397 4/20 0.65
S1PR4 known ✓ O95977 1/20 0.65
BCHE known ✓ P06276 1/20 0.65
S1PR1 known ✓ P21453 1/20 0.65
PPARG known ✓ P37231 1/20 0.65
MAOB known ✓ P27338 1/20 0.50
MEN1 O00255 3/20 0.80
KMT2A Q03164 3/20 0.80
CDC25B P30305 2/20 0.80
MAPT P10636 4/20 0.65
KDM4E B2RXH2 3/20 0.65
MAPK1 P28482 3/20 0.65
RAB9A P51151 3/20 0.65
SMN1; SMN2 Q16637 3/20 0.65
APAF1 O14727 2/20 0.65
TDP2 O95551 2/20 0.65
NPC1 O15118 2/20 0.65
LMNA P02545 2/20 0.65
POLB P06746 2/20 0.65
S100A4 P26447 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anthraquinone SCHEMBL7915429 0.97 MEN1 (0.86) MEN1KMT2ACDC25BMAPTMAOA
Nitrogen SCHEMBL28051706 0.93 MEN1 (0.80) MEN1KMT2ACDC25BMAPTMAOA
Anthraquinone SCHEMBL27684132 0.93 MEN1 (0.92) MEN1KMT2ACDC25BMAPTMAOA
Anthraquinone SCHEMBL240670 0.93 MEN1 (0.92) MEN1KMT2ACDC25BMAPTMAOA
Anthraquinone SCHEMBL31072162 0.93 MEN1 (0.92) MEN1KMT2ACDC25BMAPTMAOA
Anthraquinone SCHEMBL29358690 0.89 MEN1 (1.00) MEN1KMT2ACDC25BMAPTMAOA
Anthraquinone SCHEMBL14943 0.89 MEN1 (1.00) MEN1KMT2ACDC25BMAPTMAOA
Anthraquinone SCHEMBL1901249 0.89 MEN1 (1.00) MEN1KMT2ACDC25BMAPTMAOA
Anthraquinone SCHEMBL939193 0.87 MEN1 (0.80) MEN1KMT2ACDC25BMAPTMAOA
Anthraquinone SCHEMBL6415478 0.86 MEN1 (0.92) MEN1KMT2ACDC25BMAPTMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8206570-B2 Includes electrolysis of a solution containing an adhesion primer in contact with a surface followed by a reaction at the surface obtained, of a solution containing a protic solvent, and a radically polymerizable monomer COMMISSARIAT A L'ENERGIE ATOMIQUE, ETABLISSEMENT PUBLIC A CARACTERE INDUSTRIEL ET COMMERCIAL (FR) 2012-06-26 US claimed
US-8152986-B2 Process for forming organic films on electrically conductive or semi-conductive surfaces using aqueous solutions COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2012-04-10 US claimed
US-20080087550-A1 PROCESS FOR FORMING ORGANIC FILMS ON ELECTRICALLY CONDUCTIVE OR SEMI-CONDUCTIVE SURFACES USING AQUEOUS SOLUTIONS IN TWO STEPS COMMISSARIAT A L' ENERGIE ATOMIQUE, Etablissement Public a caractere Industriel et Commercial (FR) 2008-04-17 US claimed
US-20070289872-A1 Process for forming organic films on electrically conductive or semi-conductive surfaces using aqueous solutions COMMISSARIAT A L'ENERGIE ATOMIQUE 2007-12-20 US claimed
US-8206570-B2 Includes electrolysis of a solution containing an adhesion primer in contact with a surface followed by a reaction at the surface obtained, of a solution containing a protic solvent, and a radically polymerizable monomer COMMISSARIAT A L'ENERGIE ATOMIQUE, ETABLISSEMENT PUBLIC A CARACTERE INDUSTRIEL ET COMMERCIAL (FR) 2012-06-26 US disclosed
US-8152986-B2 Process for forming organic films on electrically conductive or semi-conductive surfaces using aqueous solutions COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2012-04-10 US disclosed
US-7959773-B2 Electroactivated film with electrocatalyst-enhanced carbon electrode LUMIMOVE, INC. (US) 2011-06-14 US disclosed
US-7842637-B2 Electroactivated film with polymer gel electrolyte LUMIMOVE, INC. (US) 2010-11-30 US disclosed
US-20090288945-A1 Electroactivated film with electrocatalyst-enhanced carbon electrode LUMIMOVE, INC. DBA CROSSLINK (US) 2009-11-26 US disclosed
WO-2009143314-A2 ELECTROACTIVATED FILM WITH POLYMER GEL ELECTROLYTE LUMIMOVE, INC., A MISSOURI CORPORATION, DBA CROSSLINK (US) 2009-11-26 WO disclosed
US-20090291843-A1 Electroactivated film with polymer gel electrolyte LUMIMOVE, INC. DBA CROSSLINK (US) 2009-11-26 US disclosed
US-20090288946-A1 Electroactivated film with layered structure LUMIMOVE, INC. DBA CROSSLINK (US) 2009-11-26 US disclosed
US-20090291844-A1 Electroactivated film with immobilized peroxide activating catalyst LUMIMOVE, INC. DBA CROSSLINK (US) 2009-11-26 US disclosed
US-20080087550-A1 PROCESS FOR FORMING ORGANIC FILMS ON ELECTRICALLY CONDUCTIVE OR SEMI-CONDUCTIVE SURFACES USING AQUEOUS SOLUTIONS IN TWO STEPS COMMISSARIAT A L' ENERGIE ATOMIQUE, Etablissement Public a caractere Industriel et Commercial (FR) 2008-04-17 US disclosed
US-20070289872-A1 Process for forming organic films on electrically conductive or semi-conductive surfaces using aqueous solutions COMMISSARIAT A L'ENERGIE ATOMIQUE 2007-12-20 US disclosed